Zentraler neuropathischer Schmerz nach Schlaganfall

T. Krause; G. J. Jungehülsing

doi:10.1055/s-0037-1616356

Nervenheilkunde, Inhaltsverzeichnis

Nervenheilkunde 2016; 35(02): 25-28
DOI: 10.1055/s-0037-1616356

Kompetenznetz Schlaganfall

Schattauer GmbH

Zentraler neuropathischer Schmerz nach Schlaganfall

Central post stroke pain

T. Krause

¹Klinik und Poliklinik für Neurologie, Charité – Universitätsmedizin Berlin

²Centrum für Schlaganfallforschung Berlin (CSB), Charité – Universitätsmedizin Berlin

,

G. J. Jungehülsing

²Centrum für Schlaganfallforschung Berlin (CSB), Charité – Universitätsmedizin Berlin

³Klinik für Neurologie, Jüdisches Krankenhaus Berlin

› Institutsangaben

Abstract

Zusammenfassung

Es besteht eine Vielzahl sich häufig überlappender Schmerzentitäten nach Schlaganfall. Zentraler neuropathischer Schmerz nach Schlaganfall (CPSP) findet sich bei ca. 8% aller Patienten. Eine direkte Schädigung des spinothalamischen Traktes ist eine Voraussetzung für die Entstehung von CPSP. Patienten weisen neben Veränderungen der Schmerz- und Temperaturwahrnehmung bilaterale Atrophien der grauen Substanz auf sowie sensorische Defizite auf der initial klinisch nicht betroffenen Körperhälfte. Für die Diagnose sind neben der zeitlichen und örtlichen (somatotopen) Korrelation zum Schlaganfall der Nachweis negativer oder positiver sensorischer Symptome sowie der Ausschluss anderer Schmerzursachen erforderlich. Die Behandlung des CPSP ist schwierig und die Studienlage für die medikamentöse Therapie unbefriedigend. Mittel der ersten Wahl sind Antikonvulsiva oder Antidepressiva unter Berücksichtigung anderer Begleiterkrankungen und gegebenenfalls in Kombination.

Summary

A number of different overlapping pain entities after stroke does exist. Central post stroke pain (CPSP) has an overall prevalence of about 8% in stroke patients. A lesion to the spinothalamic tract seems to be a necessary prerequisite for CPSP. These Patients show abnormalities in temperature and pain sensation as well as sensory abnormalities on the homologous ipsilesional body side, accompanied by bilaterally spread cortical atrophy. Besides temporal and somatotopic correlation to the stroke lesion, the diagnosis of CPSP requires the presence of pain and/or distinct positive and negative sensory signs, and the exclusion of other pain entities. Treatment of CPSP is difficult, and conclusive study data are rare. Anticonvulsants and antidepressants are drugs of first choice but co-morbidities need to be considered.

Schlüsselwörter

Schlaganfall - zentraler Schmerz - neuropathischer Schmerz

Keywords

Stroke - central pain - neuropathic pain

Volltext

Referenzen

Literatur
1 Henon H. Pain after stroke: a neglected issue. J Neurol Neurosurg Psychiatry 2006; 77 (05) 569.
2 Jonsson AC, Lindgren I, Hallstrom B, Norrving B, Lindgren A. Prevalence and intensity of pain after stroke: a population based study focusing on patients’ perspectives. J Neurol Neurosurg Psychiatry 2006; 77 (05) 590-5.
3 Dejerine J, Roussy G. Le syndrome thalamique. Rev Neurol (Paris) 1906; 14 (14) 521-32.
4 Head H, Holmes G. Sensory disturbances from cerebral lesions. Brain 1911; 34 (34) 102-254.
5 Hansen AP, Marcussen NS, Klit H, Andersen G, Finnerup NB, Jensen TS. Pain following stroke: a prospective study. Eur J Pain 2012; 16 (08) 1128-36.
6 Klit H, Finnerup NB, Overvad K, Andersen G, Jensen TS. Pain following stroke: a population-based follow-up study. PLoS One 2011; 6 (11) e27607.
7 Klit H, Finnerup NB, Jensen TS. Central poststroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 2009; 8 (09) 857-68.
8 Klit H, Finnerup NB, Andersen G, Jensen TS. Central poststroke pain: A population-based study. Pain 2011; 152 (04) 818-24.
9 Bogousslavsky J, Regli F, Uske A. Thalamic infarcts: clinical syndromes, etiology, and prognosis. Neurology 1988; 38 (06) 837-48.
10 Lampl C, Yazdi K, Roper C. Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study Stroke 2002; 33 (12) 3030-2.
11 Paciaroni M, Bogousslavsky J. Pure sensory syndromes in thalamic stroke. Eur Neurol 1998; 39 (04) 211-7.
12 Boivie J, Leijon G, Johansson I. Central post-stroke pain – a study of the mechanisms through analyses of the sensory abnormalities. Pain 1989; 37 (02) 173-85.
13 Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain 1995; 61 (02) 187-93.
14 Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry 1996; 61 (01) 62-9.
15 Greenspan JD, Ohara S, Sarlani E, Lenz FA. Allodynia in patients with post-stroke central pain (CPSP) studied by statistical quantitative sensory testing within individuals. Pain 2004; 109 (03) 357-66.
16 Leijon G, Boivie J, Johansson I. Central post-stroke pain – neurological symptoms and pain characteristics. Pain 1989; 36 (01) 13-25.
17 Vestergaard K, Nielsen J, Andersen G, Ingeman-Nielsen M, Arendt-Nielsen L, Jensen TS. Sensory abnormalities in consecutive, unselected patients with central post-stroke pain. Pain 1995; 61 (02) 177-86.
18 Krause T, Brunecker P, Pittl S, Taskin B, Laubisch D, Winter B. et al Thalamic sensory strokes with and without pain: differences in lesion patterns in the ventral posterior thalamus. J Neurol Neurosurg Psychiatry 2012; 83 (08) 776-84.
19 Sprenger T. et al. Assessing the risk of central poststroke pain of thalamic origin by lesion mapping. Brain 2012; 135 (Pt 8) 2536-45.
20 Hosomi K, Seymour B, Saitoh Y. Modulating the pain network – neurostimulation for central poststroke pain. Nature reviews Neurology 2015; 11 (05) 290-9.
21 Krause T. et al. The cortical signature of central poststroke pain: gray matter decreases in somatosensory, insular, and prefrontal cortices. Cereb Cortex. 2014 DOI:
22 Baliki MN, Schnitzer TJ, Bauer WR, Apkarian AV. Brain morphological signatures for chronic pain. PLoS One 2011; 6 (10) e26010.
23 Apkarian AV, Hashmi JA, Baliki MN. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 2011; 152 (Suppl. 03) S49-64.
24 Krause T. et al. Chronic sensory stroke with and without central pain is associated with bilaterally distributed sensory abnormalities as detected by Quantitative Sensory Testing Pain. 2015 Sep 5. Epub ahead of print.
25 Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine 1994; 23 (02) 129-38.
26 Freynhagen R, Baron R, Gockel U, Tolle TR. pain-DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Current medical research and opinion 2006; 22 (10) 1911-20.
27 Maier C. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010; 150 (03) 439-50.
28 Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F. et al Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006; 10 (01) 77-88.
29 Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiology of disease 1998; 5 (04) 209-27.
30 Finnerup NB. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14 (02) 162-73.
31 Mulla SM. et al. Management of central poststroke pain: Systematic review of randomized controlled trials. Stroke 2015; 46 (10) 2853-60.
32 Leijon G, Boivie J. Central post-stroke pain – a controlled trial of amitriptyline and carbamazepine. Pain 1989; 36 (01) 27-36.
33 Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001; 56 (02) 184-90.
34 Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain 2011; 152 (05) 1018-23.
35 Vranken JH. et al. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 2008; 136 (1–2) 150-7.
36 Jungehulsing GJ. et al. Levetiracetam in patients with central neuropathic post-stroke pain – a randomized, double-blind, placebo-controlled trial. Eur J Neurol 2013; 20 (02) 331-7.
37 Vranken JH. et al. Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial. Pain 2011; 152 (02) 267-73.
38 Demant DT. et al. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain 2014; 155 (11) 2263-73.
39 Klit H. et al. Early evoked pain or dysesthesia is a predictor of central poststroke pain. Pain 2014; 155 (12) 2699-706.
40 Cruccu G. et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14 (09) 952-70.
41 Hosomi K. et al. Electrical stimulation of primary motor cortex within the central sulcus for intractable neuropathic pain. Clin Neurophysiol 2008; 119 (05) 993-1001.